Salmon calcitonin (sCT), a 32-amino-acid peptide, is the active compon
ent in many pharmaceuticals used for the management of bone diseases.
The degradation pathways of sCT were determined, and the structures of
the major degradation products were identified. Aqueous solutions of
sCT at pH values of 3, 4, 5, and 6 were degraded, and the major degrad
ation products were detected using reversed phase and size-exclusion h
igh-performance liquid chromatography (HPLC). The degradation rate and
pathways of sCT are strongly dependent on pH in the pH range between
3 and 6. The major degradation products were isolated by semipreparati
ve HPLC and identified using a variety of spectroscopic and bioanalyti
cal techniques. The results show that sCT can undergo hydrolyses resul
ting in cleavage of the 1-2 amide bond and deamidation of the Gln(14)
and Gln(20) residues, sulfide exchange that leads to an unusual trisul
fide derivative, and dimerization to reducible and nonreducible dimers
. The mechanisms for the pathways can be rationalized from known degra
dation pathways of peptide and proteins.